DSM has reported what it describes as a “very good Q3, contributing to a strong first nine months”. For the nine months, organic sales growth was 8% with EBITDA growth at 7%. Net profit was €821m.

Feike Sijbesma, CEO/Chairman DSM Managing Board, said: “We are delighted to report another very good quarter and are confident that we can achieve our full year outlook. The continued organic sales and Adjusted EBITDA growth rates in the underlying business position us well for a strong year which would once again exceed our Strategy 2018 targets.”

“While there are currently uncertainties around macro-economic developments, we see continued good business conditions in Nutrition and most of our Materials businesses. The strategic plan that we have successfully delivered over the past few years has resulted in a robust portfolio of solution-led, higher value specialty products in Nutrition, Health & Sustainable Living. We are well placed to move forward with our ambitious 2019-2021 strategy. Above market, innovation-led organic growth, as well as inorganic growth will enable us to deliver upon our 2021 strategic targets.”

For Q3, underlying organic sales growth was 5%, with EBITDA up 7% despite negative FX impact. Nutrition saw 7% organic growth, with EBITDA increasing by 10%.